DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Empagliflozin in Patients With Cirrhosis and Ascites

Phase 2

Recruiting

Conditions: Cirrhosis
Liver Failure

Interventions: Drug: Matching Placebo
Drug: Empagliflozin 10 MG

First Posted Date: 2023-02-13

Last Posted Date: 2025-03-26

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT05726032

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

Not Applicable

Recruiting

Conditions: Firearm Injury

Interventions: Behavioral: TRUE HAVEN

First Posted Date: 2023-02-13

Last Posted Date: 2025-04-08

Lead Sponsor: Yale University

Target Recruit Count: 61770

Registration Number: NCT05723614

Locations: 🇺🇸
Fair Haven, New Haven, Connecticut, United States
🇺🇸
Hill North and South, New Haven, Connecticut, United States
🇺🇸
Beaver Hills, New Haven, Connecticut, United States

and more 1 locations

Single-Session Web-Based Training in Self-Compassion

Not Applicable

Completed

Conditions: Depression
Stress
Anxiety

Interventions: Behavioral: Relaxing with Nature
Behavioral: Compassionate Care

First Posted Date: 2023-02-06

Last Posted Date: 2023-04-19

Lead Sponsor: Yale University

Target Recruit Count: 365

Registration Number: NCT05715034

Locations: 🇺🇸
Yale, New Haven, Connecticut, United States

Nicotine Flux, a Potentially Powerful Tool for Regulating Nicotine Delivery From Electronic Cigarettes

Not Applicable

Active, not recruiting

Conditions: Nicotine Vaping

Interventions: Other: Nicotine vaping visit 1 (free-base nicotine)
Other: Nicotine vaping visit 1 (protonated nicotine)
Other: Nicotine vaping visit 2 (protonated nicotine)
Other: Nicotine vaping visit 2 (free-base nicotine)

First Posted Date: 2023-01-31

Last Posted Date: 2024-08-13

Lead Sponsor: Yale University

Target Recruit Count: 15

Registration Number: NCT05706701

Locations: 🇺🇸
Human Research Unit (HRU), New Haven, Connecticut, United States

Janus Kinase Inhibition in Sarcoidosis

Phase 2

Completed

Conditions: Sarcoidosis

Interventions: Drug: Abrocitinib 200 mg

First Posted Date: 2023-01-25

Last Posted Date: 2025-05-16

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT05696795

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

OMAR Opioid Use Disorder

Phase 1

Recruiting

Conditions: Opioid Use Disorder
Healthy Control

Interventions: Drug: [11C]OMAR

First Posted Date: 2023-01-13

Last Posted Date: 2025-04-10

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT05683184

Locations: 🇺🇸
Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven, Connecticut, United States

The Impact of Preoperative Olanzapine on Quality of Recovery After Discharge from Ambulatory Surgery

Phase 2

Recruiting

Conditions: Postoperative Nausea and Vomiting

Interventions: Drug: Olanzapine
Drug: Placebo

First Posted Date: 2023-01-09

Last Posted Date: 2024-10-08

Lead Sponsor: Yale University

Target Recruit Count: 455

Registration Number: NCT05676294

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

Phase 4

Recruiting

Conditions: End Stage Renal Disease on Dialysis

Interventions: Drug: Empagliflozin 25 mg vs Placebo
Drug: Empagliflozin 10 MG

First Posted Date: 2023-01-05

Last Posted Date: 2025-03-04

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT05671991

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Buprenorphine Integration Research and Community Health

Not Applicable

Active, not recruiting

Conditions: Opioid Use Disorder
HIV Infections
Hepatitis C

Interventions: Behavioral: NIATx Coaching

First Posted Date: 2022-12-30

Last Posted Date: 2025-04-17

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT05668780

Locations: 🇺🇸
West Virginia University, Morgantown, West Virginia, United States

Understanding Effects of Cannabis Use and Abstinence on Neural Glutamate Homeostasis

Early Phase 1

Terminated

Conditions: Cannabis Use Disorder

Interventions: Drug: [18F]FPEB with PET
Behavioral: Cannabis abstinence

First Posted Date: 2022-12-27

Last Posted Date: 2025-01-08

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT05664763

Locations: 🇺🇸
The Anlyan Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy